The benefits of COVID lockdowns on respiratory health: What factors may have contributed to the decline in hospital admissions for cystic fibrosis? - 29/11/23
Doi : 10.1016/j.resmer.2023.101061
Rebecca C. Robey a, b, ⁎ 
, Orlagh Crozier c, Arran Frame d, Katrina Martin d, Philip Ashcroft e, Nizhat Iqbal d, Peter J. Barry a, d, Andy Jones a, d, Shazaad Ahmad e, Alexander Horsley a, d
, Orlagh Crozier c, Arran Frame d, Katrina Martin d, Philip Ashcroft e, Nizhat Iqbal d, Peter J. Barry a, d, Andy Jones a, d, Shazaad Ahmad e, Alexander Horsley a, d a Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, UK
b The North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
c The University of Manchester Medical School, The University of Manchester, Oxford Road, Manchester, UK
d Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK
e Department of Virology, Manchester Medical Microbiology Partnership, Manchester University NHS Foundation Trust, Manchester, UK
⁎Corresponding author at: Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, UK.Division of InfectionImmunity and Respiratory Medicine, School of Biological SciencesThe University of ManchesterUK
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : Cystic fibrosis, Lockdown, Respiratory exacerbation, Respiratory viruses, Air pollutants
Plan
© 2023
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84
Article 101061- novembre 2023 Retour au numéro
Article précédent
- Cuff-induced tracheal “aneurysm”
- Julie Tronchetti, Jean-Baptiste Lovato, Martin Boussuges, Dionisio Maia, Philippe Astoul, Hervé Dutau
- An automatically titrating oxygen-flow system during walking in hypoxaemic post-COVID-19 patients – A randomized controlled double-blind cross-over pilot trial
- Sophie Therese Berkel, Tessa Schneeberger, Daniela Leitl, Inga Jarosch, Rainer Gloeckl, Christoph Nell, Clancy John Dennis, Andreas Rembert Koczulla
Bienvenue sur EM-consulte, la référence des professionnels de santé.